Oblique Therapeutics AB Announces Outcome of Rights Issue of SEK 14.1 Million
GOTHENBURG, Sweden, June 30, 2026 /PRNewswire/ -- Oblique Therapeutics AB ("Oblique" or the "Company") today announces the outcome of the rights issue that closed on June 30. The rights issue was fully subscribed and will provide the Company with approximately SEK 14.1 million before...
GOTHENBURG, Sweden, June 30, 2026 /PRNewswire/ -- Oblique Therapeutics AB ("Oblique" or the "Company") today announces the outcome of the rights issue that closed on June 30. The rights issue was fully subscribed and will provide the Company with approximately SEK 14.1 million before...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.